Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Instil Bio, Inc.TIL · Entity 7177 | Chief Technical Officer | May 20, 2022 | May 25, 2022 |
| Turnstone Biologics Corp.TSBX · Entity 76646 | Int. Chief Technology Officer | July 20, 2023 | July 20, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Instil Bio, Inc.
Report date May 20, 2022 · Filed May 25, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.27 · Expires 2032-05-19 | Direct | 154,237 |
Reported balance
After 2022-05-20 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-05-20 · Grant · Acquired 154,237 · Balance 154,237 F1: Twenty-five percent (25%) of the shares subject to the option vest on May 20, 2023, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date. |
Filing footnotes · ownership attribution and instrument terms
F1: Twenty-five percent (25%) of the shares subject to the option vest on May 20, 2023, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.
Turnstone Biologics Corp.
Report date July 20, 2023 · Filed July 20, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.53 · Expires 2033-05-30 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2023-07-20 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: One fourth (1/4th) of the shares subject to the option award shall vest on March 20, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: One fourth (1/4th) of the shares subject to the option award shall vest on March 20, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 20, 2022 Filed May 25, 2022 18:08 UTC | Instil Bio, Inc. TIL · Entity 7177 | GrantEmployee Stock Option (right to buy) · Derivative | 154,237 | $0.00 Strike: $7.27 | $0.00 |
DisclosureSEC source: 0001789769-22-000055 · wf-form4_165351647029928.xml · derivative · entry 1 Chiruvolu Vijay · CIK 0001851347 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,237 Underlying: Common Stock · 154,237 shares Expires 2032-05-19 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on May 20, 2023, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| March 04, 2022 Filed Mar 7, 2022 17:05 UTC | Instil Bio, Inc. TIL · Entity 7177 | GrantEmployee Stock Option (right to buy) · Derivative | 257,000 | $8.62 Strike: $8.62 | $2,215,340.00 |
DisclosureSEC source: 0001789769-22-000012 · wf-form4_164669070108181.xml · derivative · entry 1 Chiruvolu Vijay · CIK 0001851347 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,000 Underlying: Common Stock · 257,000 shares Expires 2032-03-03 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on March 4, 2023, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| May 11, 2021 Filed May 13, 2021 16:57 UTC | Instil Bio, Inc. TIL · Entity 7177 | GrantEmployee Stock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $16.25 | $0.00 |
DisclosureSEC source: 0001789769-21-000038 · wf-form4_162093944052252.xml · derivative · entry 2 Chiruvolu Vijay · CIK 0001851347 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2031-05-10 F2 · derivative.exercise_date: The option vests in forty-eight (48) equal monthly installments commencing on June 11, 2021, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| April 30, 2021 Filed May 13, 2021 16:57 UTC | Instil Bio, Inc. TIL · Entity 7177 | GrantEmployee Stock Option (right to buy) · Derivative | 154,237 | $0.00 Strike: $20.53 | $0.00 |
DisclosureSEC source: 0001789769-21-000038 · wf-form4_162093944052252.xml · derivative · entry 1 Chiruvolu Vijay · CIK 0001851347 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,237 Underlying: Common Stock · 154,237 shares Expires 2031-04-29 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on April 30, 2022, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| March 18, 2021 Filed Mar 22, 2021 20:48 UTC | Instil Bio, Inc. TIL · Entity 7177 | GrantEmployee Stock Option (right to buy) · Derivative | 240,000 | $0.00 Strike: $5.95 | $0.00 |
DisclosureSEC source: 0001209191-21-022471 · doc4.xml · derivative · entry 1 Chiruvolu Vijay · CIK 0001851347 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,000 Underlying: Common Stock · 240,000 shares Expires 2031-02-09 F1 · derivative.exercise_date: The option vests in forty-eight (48) equal monthly installments commencing on March 19, 2021, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.